"TBSF" Human Immunoglobulin for Intravenous Use

Țară: Australia

Limbă: engleză

Sursă: Department of Health (Therapeutic Goods Administration)

Ingredient activ:

normal immunoglobulin, Quantity: 60 g/L

Disponibil de la:

CSL Behring Australia Pty Ltd

INN (nume internaţional):

normal immunoglobulin

Forma farmaceutică:

Injection, solution

Compoziție:

Excipient Ingredients: maltose

Calea de administrare:

Intravenous

Unități în pachet:

50mL, 200mL

Clasă:

Medicine Listed (Export Only)

Tip de prescriptie medicala:

(S1) This Schedule is intentionally blank

Indicații terapeutice:

TBSF Human Immunoglobulin for Intravenous Use is indicated for replacement IgG therapy in: * primary immunodeficiency (PID) * symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment. TBSF Human Immunoglobulin for Intravenous Use is indicated for immunomodulatory therapy in: * Idiopathic Thrombocytopenic Purpura (ITP), in adults or children at high risk of bleeding or prior to surgery to correct the platelet count * allogeneic bone marrow transplantation * Kawasaki disease * Guillain-Barre Syndrome (GBS).

Rezumat produs:

Visual Identification: Clear, colourless solution; Container Type: Vial; Container Life Time: 3 Years; Container Temperature: Store at 2 to 8 degrees Celsius

Statutul autorizaţiei:

Listed (Export Only)

Data de autorizare:

2006-03-01